Marcin Czech - Concepedia

Author

Marcin Czech

Also Known As

Czech M, Czech, Marcin, Gyger, Pius, Klinika Pediatrii, Centrum Medyczne Kształcenia Podyplomowego, Warszawa, M CZECH, M Czech, M. CZECH, M. Czech, MARCIN CZECH, Marcin Czech

179

Publications

896

Citations

H-Index

Concepts

All Affiliations

Medical University of Warsaw Medical University of Sofia Medical University of Lodz Jagiellonian University Warsaw University of Technology Business School

About

Marcin Czech is an author at Medical University of Warsaw specializing in medicine, gastroenterology, and outcomes research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	42
2	Public Health	2	2	23
3	Health Sciences	1	1	19
4	Diabetes	1	1	10
5	Epidemiology	1	1	13

Marcin Czech

Publications

457

Citations

H-Index

Page 1

	Year	Citations
Multi-Criteria Decision Analysis (MCDA) Models in Health Technology Assessment of Orphan Drugs—a Systematic Literature Review. Next Steps in Methodology Development? Aleksandra Baran-Kooiker, Marcin Czech, Coen Kooiker Frontiers in Public Health	2018	64
The costs of heart failure in Poland from the public payer’s perspective. Polish programme assessing diagnostic procedures, treatment and costs in patients with heart failure in randomly selected outpatient clinics and hospitals at different levels of car Marcin Czech, Grzegorz Opolski, Tomasz Zdrojewski, Kardiologia Polska	2013	57
Prevalence of diabetes in Poland: a combined analysis of national databases Roman Topór‐Mądry, Bogdan Wojtyniak, Krzysztof Strojek, Diabetic Medicine	2019	37
Prevalence and Age Structure of Polypharmacy in Poland: Results of the Analysis of the National Real-World Database of 38 Million Citizens Przemysław Kardas, Filip Urbański, Aneta Lichwierowicz, Frontiers in Pharmacology	2021	36
Recommendations to overcome barriers to the use of artificial intelligence-driven evidence in health technology assessment Antal Zemplényi, Konstantin Tachkov, László Balkányi, Frontiers in Public Health	2023	34
Reimbursement Legislations and Decision Making for Orphan Drugs in Central and Eastern European Countries Krzysztof Piotr Malinowski, Paweł Kawalec, Wojciech Trąbka, Frontiers in Pharmacology	2019	29
Cost of severe hypoglycaemia in nine European countries Michał Jakubczyk, Izabela Lipka, J. Pawèska, Journal of Medical Economics	2016	25
Primary non-adherence to medication and its drivers of in Poland: findings of the analysis of the e-prescription pilot Przemysław Kardas, Janusz Cieszyński, Marcin Czech, Polskie Archiwum Medycyny Wewnętrznej	2019	21
The Prevalence of Selected Potential Drug-Drug Interactions of Analgesic Drugs and Possible Methods of Preventing Them: Lessons Learned From the Analysis of the Real-World National Database of 38 Million Citizens of Poland Przemysław Kardas, Filip Urbański, Aneta Lichwierowicz, Frontiers in Pharmacology	2021	21
Real-World Evidence of Patient Outcome Following Treatment of Advanced Gastrointestinal Stromal Tumor (GIST) with Imatinib, Sunitinib, and Sorafenib in Publicly Funded Health Care in Poland Melania Brzozowska, Waldemar Wierzba, Sylwia Szafraniec-Buryło, Medical Science Monitor Overall SurvivalGastrointestinal OncologyMedicineCancer ManagementReal-world Evidence	2019	19

Page 1